+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Salvage surgery for chemorefractory gestational trophoblastic disease



Salvage surgery for chemorefractory gestational trophoblastic disease



Journal of Clinical Oncology 12(12): 2737-2742



Purpose: To investigate and define better the role of salvage surgery for patients with chemorefractory gestational trophoblastic disease (GTD). Patients and Methods: A retrospective review of medical records at The University of Texas M.D. Anderson Cancer Center identified 33 patients with chemorefractory GTD who underwent salvage surgery between 1962 and 1991. The end points selected for analysis were serologic response and survival. Results: Initial salvage procedures consisted of 29 hysterectomies, four thoracotomies, and one nephrectomy (in conjunction with a hysterectomy). Fourteen patients (42%) had a serologic complete response (CR) to surgery (normalization of human chorionic gonadotropin (hCG)), 10 (30%) had a partial response ( gt 50% decrease in hCG level), and nine had no response ( ltoreq 50% decrease in hCG level). Of 19 patients who received further chemotherapy, eight (42%) attained a CR. Four patients underwent a second salvage surgery: two thoracotomies, one craniotomy, and one partial hepatectomy. All achieved a CR. The probability of achieving a CR was influenced by the time from diagnosis to surgery, number of preoperative disease sites, preoperative World Health Organization (WHO) score, and histologic type. Survival was influenced by the type of antecedent pregnancy, number of preoperative regimens, number of preoperative disease sites, time from diagnosis to surgery, and preoperative WHO score. Conclusion: Based on the findings of this study, it appears that a select subset of patients with chemorefractory GTD who have a limited number of clinically detectable tumor foci may benefit from salvage surgery.

(PDF emailed within 0-6 h: $19.90)

Accession: 009378034

Download citation: RISBibTeXText

PMID: 7989951

DOI: 10.1200/jco.1994.12.12.2737


Related references

Etoposide-platin combination therapy for chemorefractory gestational trophoblastic disease. Gynecologic Oncology 56(3): 421-424, 1995

EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor. Journal of Reproductive Medicine 49(6): 443-446, 2004

Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases. Gynecologic Oncology 116(1): 3-9, 2009

Hyperglycosylated hCg in the Management of Quiescent and Chemorefractory Gestational Trophoblastic Diseases. Obstetrical & Gynecological Survey 65(4): 236-237, 2010

"Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases". Gynecologic Oncology 117(3): 505-6; Author Reply 506-7, 2010

Methotrexate combined chemotherapy for chemorefractory gestational trophoblastic tumour. Zhonghua Fu Chan Ke Za Zhi 34(2): 97-100, 2001

15years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage. Gynecologic Oncology (): -, 2016

Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia. Zhonghua Fu Chan Ke Za Zhi 42(9): 595-599, 2007

Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. American Journal of Obstetrics and Gynecology 203(6): 531-539, 2011

Successful salvage therapy of resistant gestational trophoblastic disease with ifosfamide and paclitaxel. Gynecologic Oncology 97(2): 722-723, 2005

GESTATIONAL TROPHOBLASTIC DISEASE: INCREASE OF INCIDENCE IN CARLOS VAN BUREN HOSPITAL, VALPARAISO - CHILE: IGCS-0074 Gestational Trophoblastic Neoplasia. International Journal of Gynecological Cancer 25 Suppl 1: 42, 2015

Vinblastine, cisplatin and bleomycin as salvage therapy for refractory high-risk metastatic gestational trophoblastic disease. Journal of Reproductive Medicine 34(3): 189-192, 1989

Successful salvage therapy of resistant gestational trophoblastic disease with etoposide methotrexate dactinomycin vincristine and cyclophosphamide. Gynecologic Oncology 34(1): 98-100, 1989

Gestational trophoblastic disease: presentations from the XVIIth World Congress on Gestational Trophoblastic Diseases. Journal of Reproductive Medicine 59(5-6): 187-187, 2014

Gestational trophoblastic disease. Presentations from the XVth World Congress on gestational trophoblastic diseases. Journal of Reproductive Medicine 55(5-6): 182-183, 2010